SDZ 89104
Latest Information Update: 10 Aug 1994
At a glance
- Originator Novartis
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.